|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
EMPA-REG OUTCOME study with the SGLT-2 inhibitor empagliflozin (JARDIANCE) … the big question: a breakthrough?
Tranexamic acid for traumatic bleeding - transferability of the CRASH-2 data is disputed
|
|
|
NEW ON THE MARKET
|
|
Tiotropium plus olodaterol (SPIOLTO RESPIMAT) against COPD
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Flu vaccination: disadvantage for people with statutory health insurance?
Rules for collegial cooperation
|
|
|
IN BRIEF
|
|
Warning regarding Q fever from live cell therapy
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Asthma-like attacks with OCTENIDOL mouthwash solution
|
|
|
SIDE EFFECTS
|
|
Respiratory depression in children following use of tramadol
Progressive multifocal leukoencephalopathy with fumaric acid esters (FUMADERM, TECFIDERA) despite only moderate lymphopenia
Aortic aneurysm with fluoroquinolones
|
|
|
e a-t IN THE INTERNET
|
|
OCTENIDOL for MRSA decontamination?
|
|